SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017237
Filing Date
2022-08-15
Accepted
2022-08-15 08:02:26
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q impl-20220630.htm   iXBRL 10-Q 2955410
2 EX-31.1 impl-ex31_1.htm EX-31.1 20069
3 EX-31.2 impl-ex31_2.htm EX-31.2 19809
4 EX-32.1 impl-ex32_1.htm EX-32.1 9653
5 EX-32.2 impl-ex32_2.htm EX-32.2 9701
  Complete submission text file 0000950170-22-017237.txt   9005092

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20220630.xsd EX-101.SCH 67792
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20220630_lab.xml EX-101.LAB 555387
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT impl-20220630_cal.xml EX-101.CAL 45306
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20220630_pre.xml EX-101.PRE 402556
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT impl-20220630_def.xml EX-101.DEF 228457
63 EXTRACTED XBRL INSTANCE DOCUMENT impl-20220630_htm.xml XML 1244393
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 10-Q | Act: 34 | File No.: 001-40353 | Film No.: 221162442
SIC: 2834 Pharmaceutical Preparations